(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.79%) $83.19
(-1.16%) $1.619
(-0.38%) $2 338.30
(1.08%) $27.55
(0.65%) $928.10
(-0.16%) $0.933
(-0.14%) $11.01
(-0.23%) $0.799
(0.00%) $92.17
-3.19% $ 1.365
Live Chart Being Loaded With Signals
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 261 676 |
Średni wolumen | 261 312 |
Kapitalizacja rynkowa | 66.40M |
EPS | $-0.290 ( 2024-04-02 ) |
Następna data zysków | ( $-0.280 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.230 |
ATR14 | $0.00500 (0.37%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Sandercock Colin | Buy | 175 000 | Stock Option (right to buy) |
2024-03-06 | Suri Anish | Buy | 300 000 | Stock Option (right to buy) |
2024-03-06 | Millar Kerri-ann | Buy | 250 000 | Stock Option (right to buy) |
2024-03-06 | Passeri Daniel R | Buy | 400 000 | Stock Option (right to buy) |
2024-03-06 | Levisetti Matteo | Buy | 260 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
98.01 |
Last 98 transactions |
Buy: 5 498 246 | Sell: 593 660 |
Wolumen Korelacja
Cue Biopharma Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
NLTX | 0.886 |
RPHM | 0.872 |
RNAZ | 0.843 |
SGTX | 0.843 |
ACLX | 0.842 |
ADMP | 0.842 |
NISN | 0.834 |
SDIG | 0.833 |
RMRM | 0.832 |
VCXA | 0.828 |
10 Najbardziej negatywne korelacje | |
---|---|
TCBS | -0.877 |
CDW | -0.875 |
MYNZ | -0.87 |
RGP | -0.865 |
RBBN | -0.863 |
PTSI | -0.862 |
CASS | -0.858 |
HOFT | -0.858 |
LSAK | -0.846 |
FFBW | -0.844 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cue Biopharma Inc Korelacja - Waluta/Towar
Cue Biopharma Inc Finanse
Annual | 2023 |
Przychody: | $5.49M |
Zysk brutto: | $2.05M (37.41 %) |
EPS: | $-1.110 |
FY | 2023 |
Przychody: | $5.49M |
Zysk brutto: | $2.05M (37.41 %) |
EPS: | $-1.110 |
FY | 2022 |
Przychody: | $1.25M |
Zysk brutto: | $-560 828 (-45.04 %) |
EPS: | $-1.480 |
FY | 2021 |
Przychody: | $14.94M |
Zysk brutto: | $14.94M (100.00 %) |
EPS: | $-1.410 |
Financial Reports:
No articles found.
Cue Biopharma Inc
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-102, a fusion protein biologic to target and activate antigen-specific T cells to fight cancers; CUE-103 a CUE-100 series Immuno-STAT targeting the KRAS G12V mutation, including colorectal carcinoma, lung cancer, and pancreatic cancer; CUE-200 that focuses on cell surface receptors, including CD80 and/or 4-1BBL to address T cell exhaustion associated with chronic infections; and CUE-300 and CUE-400 framework to target various autoimmune diseases. Cue Biopharma, Inc. has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; LG Chem Life Sciences for the development of Immuno-STATs focused on the field of oncology; and Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej